Mohamed Zaki
Directeur Technique/Scientifique/R&D chez ADC THERAPEUTICS SA
Fortune : 800 332 $ au 31/05/2024
Profil
Mohamed Zaki is currently the Chief Medical Officer at ADC Therapeutics SA. Prior to his current position, he served as the VP & Global Head-Oncology Development at AbbVie, Inc. from 2018 to 2022.
He also held the position of Head-Clinical Development at Centocor, Inc. from 2001 to 2007 and at Sanofi-Aventis U.S.
LLC from 2007 to 2010.
Dr. Zaki holds a doctorate degree from the University of Pennsylvania and graduate and doctorate degrees from Ain Shams University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ADC THERAPEUTICS LTD
0,24% | 01/04/2024 | 233 333 ( 0,24% ) | 800 332 $ | 31/05/2024 |
Postes actifs de Mohamed Zaki
| Sociétés | Poste | Début |
|---|---|---|
| ADC THERAPEUTICS SA | Directeur Technique/Scientifique/R&D | 03/01/2023 |
Anciens postes connus de Mohamed Zaki
| Sociétés | Poste | Fin |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/12/2022 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Directeur Technique/Scientifique/R&D | 01/01/2010 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Directeur Technique/Scientifique/R&D | 01/07/2007 |
Formation de Mohamed Zaki
| University of Pennsylvania | Doctorate Degree |
| Ain Shams University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ADC THERAPEUTICS SA | Health Technology |
| ABBVIE INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
